New FDA Guidelines Hit This Company Hard

New FDA Guidelines Hit This Company Hard

Allergan (NYSE: AGN ) , the diversified health care giant best known for Botox, boasts an impressive portfolio of products. From the Lap-band surgical device to drugs that treat allergies, this has long been a stock marked by slow but steady growth. In

7
Like
Save

Comments

Write a comment

*